Skip to content
THE TIMES USA
Menu
  • ABOUT
  • CONTACT
  • LIFESTYLE
  • NATIONAL NEWS
  • BUSINESS
  • INTERNATIONAL NEWS
  • TECHNOLOGY
  • PRICE OF BUSINESS SHOW AUDIOS
Menu

Group Seeks to Radically Change the Business Model of the Pharmaceutical Industry

Posted on January 16, 2019January 14, 2019 by admin

Achieving the full societal benefits of curing chronic or life-threatening diseases will remain an elusive goal unless the pharmaceutical industry changes its economic model, according to new report by Boston Consulting Group (BCG). The report, titled Aligning Economic Incentives to Eradicate Diseases, was recently released.

The study recommends that the industry replace its current economic model, which calls for charging by treatment at the time of care, with a licensing model that is based on the entire affected population. BCG’s new approach, the payer licensing agreement (PLA), is analogous to models used by major software and media companies. When BCG tested the PLA against the current economic model for cures for the hepatitis C virus (HCV), the analysis showed that the PLA could achieve the following:

  • Triple the number of patients treated and cured within two years
  • Reduce the number of liver-related deaths by some 60%
  • Reduce the total cost to payers by approximately 30%, because patients would be treated much earlier—before the disease progresses to more costly stages
  • Provide higher and more predictable revenues and profits to pharmaceutical manufacturers

“Current economic models in the pharmaceutical industry are well designed to manage diseases, not cure them,” said Jean-Manuel Izaret, a BCG senior partner and coauthor of the study. “The solution is to price the cures on the basis of the total population rather than individual patients.”

BCG’s epidemiological and economic modeling of HCV treatment, performed in collaboration with the Center for Disease Analysis, showed that, in every market tested, patients, payers, and pharmaceutical companies would do better under a PLA.

The PLA Solves a Frustrating Dilemma 
The authors chose HCV as their test case because the disease remains a global crisis. Despite the introduction of innovative cures in 2013, more than 90% of the world’s infected population (71 million) remains uncured, a far cry from the World Health Organization’s target of eradication by 2030.

“There are many barriers to curing this population, but the dilemma created by current pricing models is one of the biggest,” said Dave Matthews, a BCG principal and study coauthor. The dilemma results because a high price per patient makes treating everyone prohibitively expensive while an affordable price is too low for pharmaceutical companies to earn back their investments.

“Switching to a population-based model such as the PLA not only makes the cure affordable, but also creates strong motivation to identify, diagnose, and treat as many patients as possible before the license expires,” Matthews explained.

Looking Beyond HCV to Curing Other Diseases
HCV serves as a robust test case, but BCG views the PLA as an attractive model for other cures as well. “We are convinced that the PLA model could be beneficial from health care, social, and economic standpoints as pharmaceutical companies bring other cures to market,” said Mark Lubkeman, a BCG senior partner and one of the study’s coauthors.

You Might Also Like...

  • Iconic Business Magazine Brand Sold for $150 Million

    Meredith Corporationtoday announced an agreement to sell the FORTUNE media brand for $150 million cash…

  • Small Business Job Growth Slowed at the End of 2018

    The Paychex | IHS Markit Small Business Employment Watch closed the year with a decline in…

  • Very Large Breaches

    By the Price of Business Show, Hosted by Kevin Price.  The Price of Business is a media…

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

VIDEO: This Week’s Best of our Network

https://www.thetimesusa.com/wp-content/uploads/2023/01/Why-the-Democrats-First-Primary-Move-to-South-Carolina-Matters.mp4

GDPR Compliance

USABR does not collect data on its visitors.  For more information visit: https://www.usabusinessradio.com/contact-us/

Contact

Contact articles@usabusinessradio.net for more information on articles on this site. BMuyco@usabusinessradio.net for all other information.

Recent Articles

  • Whose Voice Do You Listen To?
  • The Controversies Surrounding George Santos Committee Assignments
  • Read This Before You Start A Security Agency
  • Points of Leadership: Transformational Leadership
  • Confidence Slayers: Sparking Sensibilities

The Secret to Making New Rich Books Work

The Secret to Making New Rich Books Work

Also in TTUSA

  • Is Season Two of “The Kominsky Method” as Good as the First?
  • Celebrating Differences Acceptance in Twins
  • A Journey: Boardroom to Back Roads
  • What is a PEO and How Can It Help My Business?
  • 3 Ways SEO Leads to Business Growth and Success

RSS The Daily Blaze

  • How Hypnosis Can Help for Successful Weight Management
  • How to Guide the Behaviour of the Little Ones in The Child Care Industry
  • Will the FTC Move on Non Competes Hurt the Economy?
  • Republican Governors War on Big Tech or Free Speech?
  • How to Prepare a London Property for the Short-Term Rental Market

The Leader in Business News

The Leader in Business News

RSS USA Business Radio

  • Starting the New Year Out Right Financially
  • Former White House Budget Director’s Dire Warning on the Economy
  • Cody Willard on the Trial of Elon Musk
  • What’s Up with New Crypto Efforts?
  • Former Vice President Pence Joins Trump and Biden with Confidential Document Issues

RSS USA Daily Times

  • Earth’s Inner Core Seems to Be Slowing Its Spin
  • The Original Series at The Times USA
  • How To Invest Passively in Real Estate
  • Fan of Yellowstone and 1923? You Need To Hear This.
  • Music Podcast Hosted by James Cox Who Has Cerebral Palsy

RSS USA Daily Chronicles.

  • The Original Series at The Times USA
  • Make the Customer Feel Comfortable
  • Illustrator Eric M. Strong Discusses the Power of Underestimating Yourself
  • Dr. Cassandra McBride-Smith’s Commentary Feature on Price of Business Digital Network
  • Does Your Face Hurt?

RSS Price of Business

  • How Hypnosis Can Help for Successful Weight Management
  • Starting the New Year Out Right Financially
  • Former White House Budget Director’s Dire Warning on the Economy
  • Is Your Child’s 529 Plan in Danger?
  • Will the FTC Move on Non Competes Hurt the Economy?

RSS US Daily Review

  • Dr. Ann Hester’s Commentary Feature on the Price of Business Digital Network
  • The Most Common Online Degrees You Can Get
  • Investigating the Potential of Ethereum Gambling as a Mainstream Entertainment Choice
  • Everest Business Funding Lists Effective Ways to Measure Business Performance
  • The Original Series at The Times USA

PoB Digital Network

US Daily Review

USA Business Radio

USA Daily Chronicles

USA Daily Times

The Daily Blaze

The Times USA

Price of Business

© 2023 THE TIMES USA | Powered by Superbs Personal Blog theme